(Q46587038)

English

Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats

scientific article published on 19 October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16001110

Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16001110

1 reference

based on heuristic

inferred from title

author name string

Mikhail Kalinichev

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16001110

Claire Rourke

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16001110

Alex J Daniels

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16001110

Mary K Grizzle

4

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16001110

Christy S Britt

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16001110

Diane M Ignar

6

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16001110

Declan N C Jones

7

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16001110

publication date

19 October 2005

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16001110

Psychopharmacology

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16001110

182

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16001110

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16001110

220-231

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16001110

https://scigraph.springernature.com/pub.10.1007/s00213-005-0081-9

0 references

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-005-0081-9

21 January 2018

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-005-0081-9

21 January 2018

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1 reference

https://api.crossref.org/works/10.1007%2FS00213-005-0081-9

21 January 2018

Olanzapine increases weight and serum triglyceride levels.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetic ketoacidosis with olanzapine treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of olanzapine-induced weight gain with an increase in body fat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose tolerance and serum insulin levels in an animal model of obesity induced by the antipsychotic drug, sulpiride.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose tolerance and serum insulin levels in an animal model of obesity induced by sub-acute or chronic administration of antipsychotic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosing the antipsychotic medication olanzapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An animal model of antipsychotic-induced weight gain

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of olanzapine-induced weight gain in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NMDA receptor antagonists reduce restraint-induced release of prolactin in male rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Body weight gain induced by antipsychotic drugs: mechanisms and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of the effect of atypical antipsychotics on weight

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of atypical antipsychotics in bipolar depression and anxiety disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of excitotoxic hippocampal lesions in rats on risperidone- and olanzapine-induced locomotor suppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rat sex and strain differences in responses to stress

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine-induced glucose dysregulation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical implications of weight gain in schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel antipsychotics: comparison of weight gain liabilities.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic drug-induced obesity in rats: correlation between leptin, insulin and body weight during sulpiride treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic drugs and obesity: is prolactin involved?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Social influences on the amount of food eaten by Norway rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperprolactinaemia and antipsychotic therapy in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physiological evidence for the existence of prolactin releasing factor: stress-induced prolactin secretion is not linked to dopaminergic receptors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperglycemia associated with olanzapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancing outcomes in the management of treatment resistant depression: a focus on atypical antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel antipsychotics and severe hyperlipidemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and tissue distribution of olanzapine in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotics: impact on prolactin levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weight gain: side effect of atypical neuroleptics?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of housing on male and female rats: crowding stresses male but calm females.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting medication noncompliance after hospital discharge among patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antipsychotic drug sulpiride does not affect bodyweight in male rats. Is insulin resistance involved?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of olanzapine, an atypical antipsychotic, in patients with schizophrenia: results of an open-label multicenter study in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the classical antipsychotic haloperidol and atypical antipsychotic risperidone on weight gain, the oestrous cycle and uterine weight in female rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of atypical antipsychotics on serum prolactin levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigation into the effects of the novel antipsychotic ziprasidone on weight gain and reproductive function in female rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16001110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-005-0081-9

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16001110

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16001110

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46587038&oldid=2120609561"